IL1B and Alzheimer disease: Similarly, in a mouse model of AD, within 24 h after the systemic administration of LPS, cerebral IL-1β and IL-6 were induced, followed by changes in β-amyloid precursor peptide (APP) isoforms similar to those observed in AD patients (Brugg et al., 1995).